Liquid biomarkers in glioma

Area of Science:

• Neuro-oncology
• Biomarker Discovery
• Translational Medicine

Background:

• Glioma presents unique challenges for biomarker discovery, including tumor heterogeneity and the difficulty of histological examination.
• Liquid biomarkers offer a minimally invasive alternative to traditional histological methods for brain disease diagnosis.
• Current liquid biomarkers for glioma lack clinical adoption due to issues with sensitivity, specificity, and low tumor incidence hindering research.

Purpose of the Study:

• To review the sensitivity and specificity of candidate liquid biomarkers for glioma.
• To identify promising liquid biomarkers for clinical application in glioma diagnosis and treatment.
• To highlight the potential of novel specimen types and omics analyses in advancing glioma biomarker research.

Main Methods:

• Comprehensive literature review focusing on sensitivity and specificity of liquid biomarkers for glioma.
• Analysis of novel specimen types, including extracellular vesicles.
• Evaluation of comprehensive omics analysis for biomarker identification.

Main Results:

• Several candidate liquid biomarkers have been identified through advanced techniques.
• The review critically assesses the sensitivity and specificity data for each candidate.
• Challenges in clinical adoption due to glioma's heterogeneous nature are highlighted.

Conclusions:

• Liquid biomarkers hold significant promise for overcoming the limitations of traditional glioma diagnostics.
• Further multicenter studies are crucial to validate candidate biomarkers and establish new treatment strategies.
• Identifying ideal glioma biomarkers could elucidate underlying mechanisms and reveal novel therapeutic targets.